Invasive group A streptococcus infections in the intensive care unit: an unsupervised cluster analysis of a multicentric retrospective cohort
- PMID: 40506732
- PMCID: PMC12164110
- DOI: 10.1186/s13054-025-05469-6
Invasive group A streptococcus infections in the intensive care unit: an unsupervised cluster analysis of a multicentric retrospective cohort
Abstract
Background: Invasive group A streptococcus (iGAS) infection incidence is rising. These infections have been studied as a whole but can be associated with critical illness in a population with a wide array of underlying conditions, sites of infection and clinical presentations. Using an unsupervised clustering approach, we aimed to identify specific clinical phenotypes regarding presentation, management and outcome.
Methods: This was a retrospective multicentric study including all patients admitted to one of 9 ICUs of Paris University Hospitals for an iGAS infection between 01/03/2018 and 01/08/2023. iGAS infection was defined as GAS growth in any microbiological sample from a sterile site. Patients were grouped according to a clustering algorithm (k-prototypes) using a comprehensive set of clinical and biological variables available upon ICU admission. Clusters were described and clinical presentation, management and outcome were compared.
Results: 148 patients were included. According to the Silhouette criterion, patients were grouped in 3 clusters, and 7 patients remained unclassified. Cluster 1 (n = 73) comprised a greater proportion of less severely-ill female patients with painful skin and soft tissue infections, a quarter of whom had taken non-steroidal anti-inflammatory drugs. Cluster 2 (n = 42) was characterized by a high rate of respiratory infections with frequent viral co-infections. Cluster 3 (n = 26) included mostly socially deprived patients with high rates of chronic alcohol consumption and psychiatric illness, with severe organ dysfunction related to otherwise pauci-symptomatic skin and soft tissue infections. There was no significant difference in time to source control across clusters (0 [0-0] vs 0 [0-0] vs 0 [0-1] days, p = 0.12). Patients included in cluster 2 less frequently received antitoxin antibiotics than patients from clusters 1 and 3 (79% vs 45% vs 69%, p < 0.001) and tended to more frequently require ECMO support (3% vs 12% vs 0%, p = 0.07), while those from cluster 1 were less likely to receive invasive mechanical ventilation (48% vs 74% vs 77%, p = 0.005). There was no difference in ICU-mortality between clusters (19% vs 29% vs 31%, p = 0.32).
Conclusions: Based on simple and readily available clinical admission characteristics of critically ill patients with iGAS, unsupervised clustering analysis identified three specific patient populations that differed regarding ICU management. Whether tailoring management would affect outcome warrants further research.
Keywords: Critically-ill; Group A streptococcus; Intensive care unit; Necrotizing soft-tissue infection; Social deprivation; Toxic shock.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval and consent to participate: All patients received information that data extracted from their medical charts could be used for research purposes. The study was approved by an IRB (Comité d’Ethique de la Société de Réanimation de Langue Française, n° 23–037). Consent for publication: Consent for publication was provided by all authors. Competing interests: The authors declare no competing interests.
Figures
References
-
- Bagcchi S. Surge of invasive Group A streptococcus disease. Lancet Infect Dis. 2023;23:284. - PubMed
-
- Babiker A, Li X, Lai YL, Strich JR, Warner S, Sarzynski S, et al. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Lancet Infect Dis. 2021;21:697–710. - PMC - PubMed
-
- Fernández-Galilea A, Estella A, García-Garmendia JL, Loza A, Palacios-García I, Sierra-Camerino R, et al. Clindamycin but not intravenous immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections. Rev Espanola Quimioter Publicacion Of Soc Espanola Quimioter. 2022;35:475–81. - PMC - PubMed
-
- Hamada S, Nakajima M, Kaszynski RH, Otaka S, Goto H, Matsui H, et al. Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study. Eur J Clin Microbiol Infect Dis. 2022;41:263–70. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
